Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 1/20 | 0.39 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.39 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 4/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LTA4H | P09960 | 3/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
| ▸ | FDPS | P14324 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL28196286 | 0.95 | ADRB2 (0.36) | ADRB2ADRB1ADRB3TSHRCYP3A4 | |
| Methyl Alcohol SCHEMBL27880650 | 0.91 | TSHR (0.34) | ADRB2ADRB1ADRB3TSHRCYP3A4 | |
| SCHEMBL11504759 | 0.89 | CYP3A4 (0.40) | ADRB2ADRB1ADRB3TSHRCYP3A4 | |
| SCHEMBL7628864 | 0.85 | — | — | |
| SCHEMBL8953033 | 0.85 | ADRB2 (0.39) | ADRB2ADRB1ADRB3TSHRCYP3A4 | |
| SCHEMBL2155112 | 0.84 | TSHR (0.38) | ADRB2ADRB1ADRB3TSHRCYP3A4 | |
| Hydrochloric Acid SCHEMBL3155684 | 0.84 | — | — | |
| SCHEMBL3306803 | 0.82 | — | — | |
| SCHEMBL2191404 | 0.80 | TSHR (0.33) | TSHRLMNATHRBFDPS | |
| SCHEMBL10024503 | 0.80 | ADRB2 (0.41) | ADRB2ADRB1ADRB3TSHRCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3820609-B1 | USE OF N-CHELATING RUTHENIUM COMPLEXES IN THE METATHESIS REACTION | APEIRON SYNTHESIS SA (PL) | 2023-06-28 | — | — | EP | claimed |
| US-20210237045-A1 | USE OF N-CHELATING RUTHENIUM COMPLEXES IN THE METATHESIS REACTION | APEIRON SYNTHESIS S.A. (PL) | 2021-08-05 | — | — | US | claimed |
| EP-3820609-A1 | <SMALLCAPS/>? ? ?N? ? ? ? ?USE OF-CHELATING RUTHENIUM COMPLEXES IN THE METATHESIS REACTION | Apeiron Synthesis S.A. (PL) | 2021-05-19 | — | — | EP | claimed |
| US-10332650-B2 | Carbon-metal composite and method for preparing the same | DONGJIN SEMICHEM CO., LTD. (KR) | 2019-06-25 | — | — | US | claimed |
| CN-105849819-B | The method for being used to prepare carbon-metal composite material | 东进世美肯株式会社 | 2019-03-08 | — | — | CN | claimed |
| US-20160307660-A1 | Carbon-Metal Composite and Method for Preparing the Same | DONGJIN SEMICHEM CO., LTD. (KR) | 2016-10-20 | — | — | US | claimed |
| CN-105849819-A | Method for preparing carbon-metal composite | 东进世美肯株式会社 | 2016-08-10 | — | — | CN | claimed |
| CN-101014555-B | Process for the isolation of modafinil | CEPHALON INC | 2010-12-08 | — | — | CN | claimed |
| EP-1727787-B1 | NEW PROCESS FOR THE PREPARATION OF NITROOXYDERIVATIVES OF PARACETAMOL | NICOX SA (FR) | 2008-07-02 | — | — | EP | claimed |
| EP-1591445-B1 | Preparation of cabergoline form I und solvate thereof | RESOLUTION CHEMICALS LTD (GB) | 2008-05-07 | — | — | EP | claimed |
| CN-101014555-A | Process for the isolation of modafinil | CEPHALON INC (US) | 2007-08-08 | — | — | CN | claimed |
| US-7186837-B2 | Preparation of cabergoline | RESOLUTION CHEMICALS (GB) | 2007-03-06 | — | — | US | claimed |
| WO-2005105796-A1 | PREPARATION OF CABERGOLINE | RESOLUTION CHEMICALS LIMITED (GB) | 2005-11-10 | — | — | WO | claimed |
| US-20050245560-A1 | Form I; dissolving cabergoline in ethylbenzene to form a solvate, optionally adding a second solvent, crystallization; purification | RESOLUTION CHEMICALS, LTD. (GB) | 2005-11-03 | — | — | US | claimed |
| EP-1591445-A1 | Preparation of cabergoline form I und solvate therof | Resolution Chemicals Limited (GB) | 2005-11-02 | — | — | EP | claimed |
| US-6806002-B2 | COMPOSITE ELECTRODES CONTAINING ACTIVE POWDER | HYDRO-DUEBEC (CA) | 2004-10-19 | — | — | US | claimed |
| US-20010041295-A1 | Composite electrodes containing active powder | HYDRO-QUEBEC (CA) | 2001-11-15 | — | — | US | claimed |
| CN-118146343-A | Allergy antigen and epitope thereof | 朋友股份有限公司 | 2024-06-07 | — | — | CN | disclosed |
| WO-1999052848-A1 | PHOSPHODIESTERASE ISOENZYME DENOMINATED 4 (PDE 4) INHIBITING COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 1999-10-21 | — | — | WO | disclosed |
| CN-1128987-A | Novel intermediates for the preparation of antihistaminic piperidine derivatives | MERRELL DOW PHARMA (US) | 1996-08-14 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210237045-A1 | USE OF N-CHELATING RUTHENIUM COMPLEXES IN THE METATHESIS REACTION | CYC1, AP1M1, HNMT | ADRB2 1974/4885ADRB1 2081/4885ADRB3 3075/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.